Bylok – Lonza

Class 1Biochemicals, namely, monoclonal or trimeric antibodies and derivatives thereof, for in-vivo or in-vitro scientific research and development to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases and for use in laboratories, diagnostics and analytics for scientific or research use.

Class 5Pharmaceutical preparations based on human monoclonal or trimeric antibodies and derivatives thereof, to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases, and for related diagnostic or therapeutic use, and for use in related assays.

Class 9Computer software for scientific laboratory research and commercial use for applications with monoclonal or trimeric antibodies used to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases.

Class 42Medical and scientific research, protein engineering, pharmaceutical product development, industrial research and contract research services, all related to human monoclonal or trimeric antibodies to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases; Computer programming for acquisition and processing of medical data in the context of medical-scientific research, development and therapy with monoclonal or trimeric antibodies and their derivatives.

Class 45Legal services related to patent exploitation, namely patent licensing; licensing of intellectual property in the field of monoclonal or trimeric antibodies for laboratories, diagnostics and analytics for scientific or research use.